Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Processing of plasmid DNA with ColE1-like replication origin.

Zhijun Wang1, Zhenghong Yuan, Ulrich R Hengge

  • 1Key Laboratory of Medical Molecular Virology, Shanghai Medical College, Fudan University, 200032 Shanghai, People's Republic of China. zjwang@shmu.edu.cn

Plasmid
|April 28, 2004
PubMed
Summary

High-quality plasmid DNA is crucial for biopharmaceutical drug development. This review examines upstream and downstream processing challenges for ColE1-like replication origins, focusing on efficient production of pharmaceutical-grade plasmid DNA.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An AAV-based bioluminescent reporter reveals dynamic YAP/TAZ-TEAD transcriptional activity during liver injury.

Biochimica et biophysica acta. Molecular basis of disease·2026
Same author

Functional anti-preS1 antibody responses associated with viral control in chronic hepatitis B.

Gut·2026
Same author

Generation of HBV cccDNA using single-stranded M13 phage DNA for authentic minichromosome functionality.

Journal of virology·2026
Same author

Spatial-quantitative profiling of intrahepatic HBsAg heterogeneity and clustered distribution in chronic HBV infection.

JHEP reports : innovation in hepatology·2026
Same author

Repurposing screen using a robust human rhinovirus infectious clone identifies pyrvinium pamoate with antiviral activity.

Antiviral research·2026
Same author

Elevated soluble LAG-3 in chronic hepatitis B and T-cell responses to checkpoint blockade.

Antiviral research·2026

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Pharmaceutical Science

Background:

  • Plasmid DNA is increasingly used as a biopharmaceutical drug.
  • High-quality plasmid DNA is essential for drug applications.
  • ColE1-like replication origins are widely used in biotechnology.

Purpose of the Study:

  • To review challenges in upstream and downstream processing of plasmid DNA for drug applications.
  • To discuss the regulation of ColE1-like origin replication in upstream processing.
  • To analyze methods for efficient production of pharmaceutical-grade plasmid DNA.

Main Methods:

  • Review of current literature on plasmid DNA processing.
  • Analysis of replication control mechanisms for ColE1-like origins.

Related Experiment Videos

  • Evaluation of simple, robust, and scalable downstream processing techniques.

    • Main Results:

    • Identified key issues in upstream plasmid DNA replication control.
    • Evaluated various downstream processing methods for scalability and efficiency.
    • Highlighted methods suitable for pharmaceutical-grade plasmid DNA production.

    Conclusions:

    • Optimizing upstream replication regulation is vital.
    • Scalable and robust downstream methods are critical for pharmaceutical applications.
    • Efficient production of high-quality plasmid DNA is achievable through targeted processing improvements.